Seeking Alpha

MNKD
MannKind Corporation

5/27/2012, 5:46 PM ET
52wk high:
52wk low:
EPS:
PE:
Div Rate:
Yield:
Market Cap:
Volume:
MNKD Market Currents more »
MNKD in Focus more »
MNKD Instablog posts more »
  • "The Rise of Mannkind"
    Sat, Jun 25, 2011 • WCoastGuynCA • Comment!
  • Stocks that are generating the most revenue for institutional lenders - may be a better list than most expensive stocks to short
    Mon, May 9, 2011 • shortside • 2 Comments
  • Musings on a Partner for Afrezza
    Thu, Mar 3, 2011 • jbossart • 1 Comment
  • Trading MNKD Mannkind Options
    Tue, Feb 15, 2011 • JISmall2002 • Comment!
  • Top Biotech Stocks for 2011 and January Catalyst Event Dates.
    Thu, Jan 27, 2011 • BioPharma Investor • Comment!
Write a post on MNKD
MNKD StockTalks
MNKD vs. ETF Alternatives
Company Description

MannKind Corporation is a biopharmaceutical company focused on the discovery, development and commercialization of therapeutic products for diseases such as diabetes and cancer. Our lead product candidate, AFRESA, is an ultra rapid-acting insulin that has completed Phase 3 clinical trials... More

Sector: Healthcare
Industry: Biotechnology
Country: United States